Rajiv Malik

This profile gathers the share dealings of Rajiv Malik across 3 companies, led by Mylan Laboratories Inc, Viatris Inc and Mylan II B.V. We count 179 filings; the first trade dates from 31 January 2007 and the latest from 4 March 2025.

On the open market, the record shows 1 purchase worth €35k and 30 sales worth €43.5M. The net balance comes to €43.4M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 56 share grants and 88 option exercises.

The latest filing, published on 5 March 2025, reports an option exercise in Viatris Inc. The clock since the last published purchase (17 March 2008) now reads 6,795 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.